Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 8/2019

21-03-2019

Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome

Auteurs: Livia Guadagnoli, Ece A. Mutlu, Bethany Doerfler, Ammoura Ibrahim, Darren Brenner, Tiffany H. Taft

Gepubliceerd in: Quality of Life Research | Uitgave 8/2019

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Food-related quality of life (FRQoL) evaluates the impact of diet, eating behaviors, and food-related anxiety on a person’s quality of life. This is the first study to evaluate FRQoL in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), two illnesses where food and diet are of importance.

Methods

One hundred seventy-five participants (80 IBS, 95 IBD) participated in the study by completing measures evaluating FRQoL, psychological distress, and health-related quality of life. Primary analyses evaluated differences in FRQoL between IBD and IBS patients. Secondary analyses compared differences based on remission status, dietary use, and dietary consultation, as well as evaluated potential predictors of FRQoL.

Results

IBD patients in remission report the highest FRQoL (IBD-remission: 91.2 (26.5) vs. IBD-active: 67.7 (19.6) and IBS-active: 67.6 (18.3), p < .001). Using more dietary treatments is associated with decreased FRQoL for IBS (r = − 0.23, p < .05) and IBD patients (r = − 0.31, p < .01). IBS patients are more likely to use dietary treatments than IBD (IBS = 81% vs. IBD = 64%, p < .01), with self-directed diets being the most commonly used approach. Symptom severity is the strongest predictor of FRQoL in both groups (IBD: R2 = .27, p < .01; IBS: R2 = .23, p < .001).

Conclusion

FRQoL is a unique construct for IBD and IBS patients that can be influenced by several clinical and dietary factors, including number of diets and type of diet used, depending on the diagnosis. Thus, FRQoL should be considered when working with both IBD and IBS patients.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
8.
go back to reference Amouretti, M., Le Pen, C., Gaudin, A. F., Bommelaer, G., Frexinos, J., Ruszniewski, P., et al. (2006). Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterologie Clinique et Biologique, 30(2), 241–246. CrossRef Amouretti, M., Le Pen, C., Gaudin, A. F., Bommelaer, G., Frexinos, J., Ruszniewski, P., et al. (2006). Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterologie Clinique et Biologique, 30(2), 241–246. CrossRef
14.
go back to reference Dean, B. B., Aguilar, D., Barghout, V., Kahler, K. H., Frech, F., Groves, D., et al. (2005). Impairment in work productivity and health-related quality of life in patients with IBS. The American Journal of Managed Care, 11(Suppl 1), 17–26. Dean, B. B., Aguilar, D., Barghout, V., Kahler, K. H., Frech, F., Groves, D., et al. (2005). Impairment in work productivity and health-related quality of life in patients with IBS. The American Journal of Managed Care, 11(Suppl 1), 17–26.
15.
go back to reference Koloski, N. A., Boyce, P. M., Jones, M. P., & Talley, N. J. (2012). What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful? Quality Life Research, 21(5), 829–836. https://​doi.​org/​10.​1007/​s11136-011-9985-5. CrossRef Koloski, N. A., Boyce, P. M., Jones, M. P., & Talley, N. J. (2012). What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful? Quality Life Research, 21(5), 829–836. https://​doi.​org/​10.​1007/​s11136-011-9985-5. CrossRef
16.
go back to reference Daniel, J. M. (2002). Young adults’ perceptions of living with chronic inflammatory bowel disease. Gastroenterology Nursing, 25(3), 83–94. CrossRef Daniel, J. M. (2002). Young adults’ perceptions of living with chronic inflammatory bowel disease. Gastroenterology Nursing, 25(3), 83–94. CrossRef
26.
go back to reference Drisko, J., Bischoff, B., Hall, M., & McCallum, R. (2006). Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. Journal of the American College of Nutrition, 25(6), 514–522. CrossRef Drisko, J., Bischoff, B., Hall, M., & McCallum, R. (2006). Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. Journal of the American College of Nutrition, 25(6), 514–522. CrossRef
29.
go back to reference Lomer, M. C., Hart, A. L., Verjee, A., Daly, A., Solomon, J., & McLaughlin, J. (2017). What are the dietary treatment research priorities for inflammatory bowel disease? A short report based on a priority setting partnership with the James Lind Alliance. Journal of Human Nutrition and Dietetics, 30(6), 709–713. https://​doi.​org/​10.​1111/​jhn.​12494. CrossRefPubMed Lomer, M. C., Hart, A. L., Verjee, A., Daly, A., Solomon, J., & McLaughlin, J. (2017). What are the dietary treatment research priorities for inflammatory bowel disease? A short report based on a priority setting partnership with the James Lind Alliance. Journal of Human Nutrition and Dietetics, 30(6), 709–713. https://​doi.​org/​10.​1111/​jhn.​12494. CrossRefPubMed
36.
go back to reference Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods, 39(2), 175–191. CrossRef Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods, 39(2), 175–191. CrossRef
37.
go back to reference Bernstein, C. N., Fried, M., Krabshuis, J., Cohen, H., Eliakim, R., Fedail, S., et al. (2010). World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflammatory Bowel Diseases, 16(1), 112–124. CrossRef Bernstein, C. N., Fried, M., Krabshuis, J., Cohen, H., Eliakim, R., Fedail, S., et al. (2010). World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflammatory Bowel Diseases, 16(1), 112–124. CrossRef
39.
go back to reference Harvey, R. F., & Bradshaw, M. J. (1980). Measuring Crohn’s disease activity. The Lancet, 1(8178), 1134–1135. CrossRef Harvey, R. F., & Bradshaw, M. J. (1980). Measuring Crohn’s disease activity. The Lancet, 1(8178), 1134–1135. CrossRef
41.
go back to reference Walmsley, R., Ayres, R., Pounder, R., & Allan, R. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32. CrossRef Walmsley, R., Ayres, R., Pounder, R., & Allan, R. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32. CrossRef
44.
go back to reference Francis, C. Y., Morris, J., & Whorwell, P. J. (1997). The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacology and Therapeutics, 11(2), 395–402. CrossRef Francis, C. Y., Morris, J., & Whorwell, P. J. (1997). The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacology and Therapeutics, 11(2), 395–402. CrossRef
47.
go back to reference Patrick, D. L., Drossman, D. A., Frederick, I. O., DiCesare, J., & Puder, K. L. (1998). Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure. Digestive Diseases and Science, 43(2), 400–411. CrossRef Patrick, D. L., Drossman, D. A., Frederick, I. O., DiCesare, J., & Puder, K. L. (1998). Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure. Digestive Diseases and Science, 43(2), 400–411. CrossRef
50.
go back to reference Jones, M. P., Bratten, J., & Keefer, L. (2007). Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet. The American Journal of Gastroenterology, 102(10), 2232–2237. CrossRef Jones, M. P., Bratten, J., & Keefer, L. (2007). Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet. The American Journal of Gastroenterology, 102(10), 2232–2237. CrossRef
51.
go back to reference Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., et al. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96(3), 804–810. CrossRef Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., et al. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96(3), 804–810. CrossRef
54.
go back to reference Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale: Lawrence Erlbaum. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale: Lawrence Erlbaum.
Metagegevens
Titel
Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome
Auteurs
Livia Guadagnoli
Ece A. Mutlu
Bethany Doerfler
Ammoura Ibrahim
Darren Brenner
Tiffany H. Taft
Publicatiedatum
21-03-2019
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-019-02170-4